Table 3.
Representative research of AI for lung cancer treatment based on pathologic images.
Application | Author | Year | Sample size of WSIs | Algorithm | Task | Performance |
---|---|---|---|---|---|---|
Classification | Coudray et al.18 | 2018 | 1634 | Deep CNN (Inception-V3) | Classification of LUAD, LUSC, or normal lung tissue and prediction of 10 most commonly mutated genes in LUAD | AUCs: 0.97 for classification, 0.733–0.856 for genomic prediction on testing dataset |
Khosravi et al.92 | 2018 | 12,139 | CNN Inception-V1 and Inception-V3 | Discrimination of LUAD and LUSC | AUC: 0.92 on testing dataset | |
Wang et al.93 | 2020 | 939 | Weakly Supervised Deep Learning | Classification of carcinoma types | Accuracy: 0.973 on testing dataset | |
Yang et al. 94 | 2021 | 741, 318, and 212 from two hospitals, and 422 from TCGA | EfficientNet-B5- and ResNet-50-based deep learning methods | Classification of LUAD, LUSC, SCLC, pulmonary tuberculosis, organizing pneumonia, and normal lung tissue | AUCs: 0.918–0.978 on testing dataset | |
Chen et al.95 | 2021 | 9662 | Deep learning | Classification of lung cancer types | AUCs: 0.9594 for LUAD, and 0.9414 for LUSC on testing dataset | |
Zheng et al.96 | 2021 | 4818 | Graph-transformer | Classification of LUAD, LUSC, or normal lung tissue | Accuracy: 0.912 on five-fold cross-validation | |
Wang et al.97 | 2019 | 1337 from TCGA, 345 from NLST, 102 from CHCAMS, and 130 from SPORE | CNN | Transformation of pathological images | Accuracy: 0.901 on independent testing dataset | |
Enhancement of Oncology Care | Yu et al.98 | 2016 | 2186 from TCGA, and 294 from TMA | Machine learning | Prognosis prediction | AUC: 0.81 on testing dataset |
Fu et al.99 | 2020 | 17,355 histopathology slide images from 28 cancer types | Inception-V4 deep learning and transfer learning | Classification of cancer types | Average AUC: 0.99 for 14 cancers on held-back validation dataset | |
Kapil et al.100 | 2021 | 151 | Deep learning | Assessment of PD-L1 expression and survival analysis | C-index: 0.93 on testing dataset | |
Qaiser et al.101 | 2022 | 1122 | Weakly supervised CNN | Prediction of disease outcome | C-index: 0.7033 on testing dataset | |
Choi et al.102 | 2022 | 802 | Deep learning | Assessment of PD-L1 expression | C-index: 0.902 for pathologists with AI assistance | |
Lee et al.27 | 2022 | 3950 patients with kidney, breast, lung, and uterine cancers | Graph DNN | Prognosis prediction | C-index: 0.731 on NLST dataset, 0.709 on TCGA dataset | |
Chen et al.103 | 2022 | 6592 gigapixel WSIs from 5720 patient samples across 14 cancer types from the TCGA | AMIL network for processing WSIs, SNN for processing molecular data features, and deep-learning-based MMF | Prognosis prediction | C-index: 0.578 for AMIL, 0.606 for SNN, and 0.644 for MMF on five-fold cross-validation |
AI: Artificial intelligence; AMIL: Attention-based multiple-instance learning; AUC: Area under the curve; CHCAMS: Chinese Academy of Medical Sciences; CNNs: Convolutional neural networks; DNN: Deep neural networks; LSCC: Lung squamous cell carcinoma; LUAD: Lung adenocarcinoma; LUSC: Lung squamous cell carcinoma; MMF: Multimodal fusion; NLST: National Lung Screening Trial; NSCLC: Non-small cell lung cancer; PD-L1: Programed death ligand-1; SCLC: Small cell lung cancer; SNN: Self-normalizing network; SPORE: Specialized Programs of Research Excellence; TCGA: The Cancer Genome Atlas; TMA: Stanford tissue microarray; WSIs: Whole slide images.